Evidence map›Paper›PMID 35499170›Full record

ArticleJournal of diabetes science and technology2022

Diabetes Technology Meeting 2021.

Nicole Y Xu, Kevin T Nguyen, Ashley Y DuBord, John Pickup, Jennifer L Sherr, Hazhir Teymourian, Eda Cengiz, Barry H Ginsberg, Claudio Cobelli, David Ahn and 11 more

Abstract read
In one paragraph

Article in Journal of diabetes science and technology, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed.

  1. Review
  2. Article
  3. Article
  4. Article
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

21 authors.

Nicole Y XuDiabetes Technology Society, Burlingame, CA, USA.ORCID 0000-0001-9353-8819
Kevin T NguyenDiabetes Technology Society, Burlingame, CA, USA.ORCID 0000-0001-9102-6537
Ashley Y DuBordUniversity of California, San Francisco, San Francisco, CA, USA.ORCID 0000-0002-1478-7065
John PickupKing's College London, London, UK.ORCID 0000-0002-4373-3269
Jennifer L SherrYale University, New Haven, CT, USA.ORCID 0000-0001-9301-3043
Hazhir TeymourianUniversity of California, San Diego, La Jolla, CA, USA.ORCID 0000-0003-0025-4732
Eda CengizUniversity of California, San Francisco, San Francisco, CA, USA.
Barry H GinsbergDiabetes Technology Consultants, Arlington, VA, USA.ORCID 0000-0001-5404-826X
Claudio CobelliUniversity of Padova, Padova, Italy.ORCID 0000-0002-0169-6682
David AhnMary & Dick Allen Diabetes Center at Hoag, Newport Beach, CA, USA.ORCID 0000-0002-8941-8459
Riccardo BellazziUniversity of Pavia, Pavia, Italy.ORCID 0000-0002-6974-9808
B Wayne BequetteRensselaer Polytechnic Institute, Troy, NY, USA.ORCID 0000-0002-6472-1902
Laura Gandrud PickettInternational Diabetes Center, Minneapolis, MN, USA.ORCID 0000-0001-5325-1688
Linda ParksUniversity of California, San Francisco, San Francisco, CA, USA.ORCID 0000-0002-8437-4450
Elias K SpanakisBaltimore VA Medical Center, Baltimore, MD, USA.ORCID 0000-0002-9352-7172
Umesh MasharaniUniversity of California, San Francisco, San Francisco, CA, USA.ORCID 0000-0002-3269-804X
Halis K AkturkBarbara Davis Center for Diabetes, University of Colorado Anschutz Medical Campus, Aurora, CO, USA.ORCID 0000-0003-4518-5179
John S MelishUniversity of Hawai'i, Honolulu, HI, USA.ORCID 0000-0002-0365-7695
Sarah KimUniversity of California, San Francisco, San Francisco, CA, USA.ORCID 0000-0002-3599-5509
Gu Eon KangThe University of Texas at Dallas, Richardson, TX, USA.ORCID 0000-0002-4791-6839
David C KlonoffDiabetes Research Institute, Mills-Peninsula Medical Center, San Mateo, CA, USA.ORCID 0000-0001-6394-6862

Funding

Yale Clinical and Translational Science Award (U Component)UL1TR001863 · NCATS · YALE UNIVERSITY · PI John H. Krystal, LUCILA OHNO-MACHADO · 2016 to 2026
$102.9M
Yale Diabetes Research CenterP30DK045735 · NIDDK · YALE UNIVERSITY · PI GERALD I SHULMAN · 1993 to 2026
$44.0M
Continuous Glucose Monitoring in Insulin Treated Hospitalized Veterans with DM2 at Higher Risk for HypoglycemiaI01CX001825 · VA · BALTIMORE VA MEDICAL CENTER · PI SPANAKIS, ILIAS · 2018 to 2023
–
CSRD VA I01 CX001825NCATS NIH HHS UL1 TR001863NIDDK NIH HHS P30 DK045735
6 · The paper itself

Abstract

Diabetes Technology Society hosted its annual Diabetes Technology Meeting on November 4 to November 6, 2021. This meeting brought together speakers to discuss various developments within the field of diabetes technology. Meeting topics included blood glucose monitoring, continuous glucose monitoring, novel sensors, direct-to-consumer telehealth, metrics for glycemia, software for diabetes, regulation of diabetes technology, diabetes data science, artificial pancreas, novel insulins, insulin delivery, skin trauma, metabesity, precision diabetes, diversity in diabetes technology, use of diabetes technology in pregnancy, and green diabetes. A live demonstration on a mobile app to monitor diabetic foot wounds was presented.

Indexed as

Diabetes MellitusDiabetes Mellitus, Type 1Blood GlucoseBlood Glucose Self-MonitoringFemaleHumansInsulinInsulin Infusion SystemsPregnancyTechnologyBlood GlucoseInsulindiabetesdigital healthglucoseinsulinsoftwaretechnology

Identifiers

PMID35499170
PMCPMC9264449

What Socratic holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.